{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:11:08Z","timestamp":1789398668989,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4113,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1600-6143.2011.03612.x","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T21:04:39Z","timestamp":1312405479000},"page":"1885-1895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Complement Activation During Liver Transplantation\u2014Special Emphasis on Patients With Atypical Hemolytic Uremic Syndrome"],"prefix":"10.1016","volume":"11","author":[{"given":"A.R.","family":"Koskinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tukiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Arola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.K.","family":"H\u00f6ckerstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Isoniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.","family":"Jokiranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2011.03612.x_bib1","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib2","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib3","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/318203","article-title":"Factor H mutations in hemolytic uremic syndrome cluster in exons 18\u201320, a domain important for host cell recognition","volume":"68","author":"Richards","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome","volume":"68","author":"Perez-Caballero","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","article-title":"The molecular basis of familial hemolytic uremic syndrome: Mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20","volume":"12","author":"Caprioli","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib8","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.4049\/jimmunol.177.9.6308","article-title":"Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces","volume":"177","author":"Ferreira","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib9","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1074\/jbc.M900814200","article-title":"Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome","volume":"284","author":"Lehtinen","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib10","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J Med Genet"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib11","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2005010103","article-title":"Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome","volume":"16","author":"Kavanagh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib12","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib13","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","article-title":"International Registry of Recurrent and Familial HUS\/TTP. Familial haemolytic uraemic syndrome and an MCP mutation","volume":"362","author":"Noris","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib14","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fremeaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic-uremic syndrome","volume":"360","author":"Nurnberger","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib18","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/j.1600-6143.2009.02817.x","article-title":"Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome","volume":"9","author":"Chatelet","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/j.ajkd.2009.08.011","article-title":"Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation","volume":"55","author":"Davin","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib20","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMc1001060","article-title":"Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome","volume":"362","author":"Zimmerhackl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2215\/CJN.00050505","article-title":"International Registry of Recurrent and Familial HUS\/TTP. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: Prognostic significance of genetic background","volume":"1","author":"Bresin","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1399-3046.2008.00910.x","article-title":"Hemolytic uremic syndrome recurrence after renal transplantation","volume":"12","author":"Loirat","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib23","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib24","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(02)08560-4","article-title":"Combined kidney and liver transplantation for familial haemolytic uraemic syndrome","volume":"359","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00467-003-1371-2","article-title":"Attempted treatment of factor H deficiency by liver transplantation","volume":"19","author":"Cheong","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib26","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2005.00783.x","article-title":"Hemolytic uremic syndrome: A fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation","volume":"5","author":"Remuzzi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib27","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1600-6143.2006.01375.x","article-title":"Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation","volume":"6","author":"Saland","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-6143.2007.02029.x","article-title":"Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H","volume":"8","author":"Jalanko","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2215\/CJN.02170508","article-title":"Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome","volume":"4","author":"Saland","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib30","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1681\/ASN.2008080906","article-title":"Liver-kidney transplantation to cure atypical hemolytic uremic syndrome","volume":"20","author":"Saland","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib31","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1600-6143.2010.03228.x","article-title":"Successful isolated liver transplantation in a child with atypical hemolytic uremic syndrome and a mutation in complement factor H","volume":"10","author":"Haller","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00007890-199304000-00022","article-title":"Complement activation during liver transplantation","volume":"55","author":"Tomasdottir","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1399-0012.2005.00334.x","article-title":"Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome","volume":"19","author":"Yassa","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib34","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/sj.bjc.6600614","article-title":"Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells","volume":"87","author":"Junnikkala","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib35","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib36","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.4049\/jimmunol.181.11.8068","article-title":"A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia\/reperfusion injury","volume":"181","author":"Huang","year":"2008","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib37","first-page":"2304","article-title":"A complement-dependent balance between hepatic ischemia\/reperfusion injury and liver regeneration in mice","volume":"119","author":"He","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/SLA.0b013e3181a38f45","article-title":"Complement-mediated ischemia-reperfusion injury: Lessons learned from animal and clinical studies","volume":"249","author":"Diepenhorst","year":"2009","journal-title":"Ann Surg"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/gast.1997.v112.pm9041253","article-title":"Complement activation after ischemia-reperfusion in human liver allografts: Incidence and pathophysiological relevance","volume":"112","author":"Scoazec","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib40","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/TP.0b013e3181663366","article-title":"Intrahepatic complement activation, sinusoidal endothelial injury, and lactic acidosis are associated with initial poor function of the liver after transplantation","volume":"85","author":"Silva","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib41","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1172\/JCI107708","article-title":"Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia","volume":"53","author":"Charlesworth","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2249.1995.tb03601.x","article-title":"The kinetics and distribution of C9 and SC5b-9 in vivo: Effects of complement activation","volume":"100","author":"Greenstein","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib43","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/00007890-199457110-00010","article-title":"Complement system activation during orthotopic liver transplantation in man. Indications of peroperative complement system activation in the gut","volume":"57","author":"Ronholm","year":"1994","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/lt.20061","article-title":"Leeds Liver Group. Complement membrane attack complex and hemodynamic changes during human orthotopic liver transplantation","volume":"10","author":"Bellamy","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib45","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.4049\/jimmunol.0900550","article-title":"A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury","volume":"183","author":"He","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib46","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0016-5085(94)90178-3","article-title":"Expression of complement-regulatory proteins in normal and UW-preserved human liver","volume":"107","author":"Scoazec","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib47","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/01.CIR.0000087404.53661.F8","article-title":"Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial","volume":"108","author":"Mahaffey","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib48","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.0000087447.12918.85","article-title":"Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial","volume":"108","author":"Granger","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2011.03612.x_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.297.1.43","article-title":"Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial","volume":"297","author":"Armstrong","year":"2007","journal-title":"JAMA"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2011.03612.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522280800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522280800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2011.03612.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:54:47Z","timestamp":1761627287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522280800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1600613522280800"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03612.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement Activation During Liver Transplantation\u2014Special Emphasis on Patients With Atypical Hemolytic Uremic Syndrome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03612.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}